Access cutting-edge obesity treatment through this clinical trial at a research site in Statesville. Study-provided care at no cost to qualified participants.
Access obesity specialists in Statesville at no cost
This study follows strict safety protocols and ethical guidelines
All study-related obesity treatment provided free
The main aim of the study is to assess the effect of RO7204239 in combination with tirzepatide, compared to placebo in combination with tirzepatide, on body weight loss after 48 weeks of treatment in adults with obesity or overweight with at least one weight-related comorbidity, but without diabetes mellitus (DM). The study comprises of a 4-week screening period; a 48-week core treatment period, where all participants will receive tirzepatide as background treatment and will be randomized to one
Sponsor: Hoffmann-La Roche
Check if you qualify for this obesity clinical trial in Statesville, NC
If you're searching for obesity treatment options in Statesville, NC, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Statesville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced obesity specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.